The use of agents to block an antigen-specific immune response. An example is the administration of anti-Rh antibodies (Rh0 immune globulin) to Rh-negative mothers during the 28th week of pregnancy to prevent the formation of maternal antibodies that cause erythroblastosis fetalis in the Rh-positive newborn.